RAPT Therapeutics Inc (RAPT)

1.67 +0.04 (+2.45%) USD  |  NASDAQ  |  Jan 03, 16:00
1.65 -0.02 (-1.20%) After-Hours: 06:09
More

RAPT Therapeutics Research and Development Expense (Annual): 101.00M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
AbbVie Inc 8.453B
Biomarin Pharmaceutical Inc 746.77M
Arbutus Biopharma Corp 73.70M
Assembly Biosciences Inc 48.90M
GlycoMimetics Inc 20.07M